What is HHC? Understanding Its Risks and Legal Status in the UK
What is HHC? Understanding Its Risks and Legal Status in the UK
At CB1 Medical, we often see questions about HHC, or hexahydrocannabinol. It is sometimes marketed online as a THC alternative, but the science, safety and legal position are more complicated than those claims suggest.
HHC is a semi-synthetic cannabinoid with THC-like effects. Research into its effects in humans is still limited, products sold outside regulated medical pathways may vary considerably in strength and composition, and its legal status in the UK sits within an evolving framework for psychoactive semi-synthetic cannabinoids. This guide explains what HHC is, how it is made, what current research tells us and how it differs from prescribed medical cannabis.
Contents
What Is HHC?
HHC stands for hexahydrocannabinol, a cannabinoid that is chemically similar to THC.
Although trace amounts of HHC-related compounds may occur naturally under some conditions, the HHC found in commercial products is generally produced through chemical conversion and is therefore usually described as a semi-synthetic cannabinoid.
Scientific work on HHC dates back to the 1940s, but commercial products only became widely visible in recreational markets around 2021.
A detailed 2024 scientific review of HHC and related semi-synthetic cannabinoids explains how hemp-derived CBD became a common starting material for modern HHC production.
How Is HHC Different From THC and CBD?
HHC is structurally related to THC, but the molecules are not identical.
Commercial HHC typically contains two main forms, or epimers:
- 9R-HHC: appears to interact more strongly with cannabinoid receptors and is considered the more pharmacologically active form.
- 9S-HHC: has much weaker activity at those receptors.
THC is the best-known intoxicating cannabinoid in cannabis. CBD, by contrast, is generally considered non-intoxicating and has a different pharmacological profile.
If you want a broader explanation of these compounds and their role in prescribed treatment, read our guide to what medical cannabis is.
How Is HHC Made?
Modern commercial HHC is commonly produced from hemp-derived CBD through several chemical steps.
One established route first converts CBD into a mixture of THC-like compounds. These are then subjected to hydrogenation, a chemical process that adds hydrogen and produces HHC.
The resulting material usually contains a mixture of 9R-HHC and 9S-HHC. Because production methods and purification standards can differ, the final composition of unregulated products may also vary.
What Effects Does HHC Have?
HHC can produce THC-like psychoactive effects, although the intensity may vary according to the product, dose and ratio of HHC epimers.
Reported effects can include:
- Changes in perception or mood
- Relaxation or sedation
- Drowsiness
- Changes in coordination or reaction time
- Anxiety or restlessness in some people
Because HHC products outside regulated medical pathways can vary considerably in strength and composition, the effects can also be difficult to predict.
What Does the Research Say About HHC?
The human evidence base for HHC remains much smaller than the evidence base for THC or CBD, but research is beginning to develop.
A 2025 forensic toxicology study examined HHC after both inhaled and oral administration. Researchers measured HHC and its metabolites in blood and also assessed psychomotor effects and drug-test detection.
The study found measurable impairment following HHC use and reported psychomotor effects that were comparable with THC under the study conditions.
Earlier research was largely preclinical. A major review of HHC chemistry and pharmacology found that 9R-HHC showed THC-like activity in laboratory and animal research while noting the major gaps that still existed in human pharmacology.
So while we now know more about HHC than we did a few years ago, there is still not enough evidence to establish a recognised medical role, standard therapeutic dose or long-term safety profile.
Is HHC Safe?
There is not enough high-quality evidence to describe HHC as safe for routine medical use.
Potential concerns include:
- Impairment of coordination and psychomotor performance
- Drowsiness or sedation
- Anxiety or other unwanted psychological effects
- Uncertain dose and potency in unregulated products
- Possible residual solvents or by-products from chemical production
- Limited information about repeated or long-term exposure
This is fundamentally different from prescribed medical cannabis, where treatment takes place within a clinical pathway and patients receive product information, prescribing oversight and ongoing review. You can read more in our medical cannabis patient information guide.
Is HHC Legal in the UK?
HHC should not be treated as a straightforward legal alternative to THC in the UK.
The UK has been reviewing the legal controls around HHC and other psychoactive semi-synthetic cannabinoids. The Advisory Council on the Misuse of Drugs has recommended that compounds in this group should be controlled as Class B drugs and placed in Schedule 1 of the Misuse of Drugs Regulations.
The ACMD has also recommended updating the UK’s generic cannabinoid controls so that psychoactive semi-synthetic cannabinoids are captured more clearly by existing legislation.
You can read the current UK Government and ACMD material on semi-synthetic cannabinoids for the latest regulatory position.
For a wider explanation of UK cannabis law and how prescribed medical cannabis differs from recreational cannabis, read our guide to cannabis legislation in the UK.
Can HHC Show Up on a Drug Test?
Yes, HHC may interfere with or trigger some cannabinoid drug tests.
Research published in 2024 found that HHC and related compounds could cross-react with some immunoassay screening tests designed to detect THC or its metabolites.
A more recent 2025 study also found cross-reactivity with on-site cannabinoid tests following HHC administration.
You can read the research on HHC and cannabis drug testing and the newer human HHC administration study.
HHC and Medical Cannabis Treatment
HHC is not an established medicine within routine UK medical cannabis treatment.
By contrast, medical cannabis has been legally available on specialist prescription in the UK since 2018. Treatment is considered individually based on a patient’s diagnosis, symptoms, previous treatments, medical history and potential risks.
At CB1 Medical, prescribed products can include formulations such as flower, oils, pastilles and vape cartridges where clinically appropriate.
You can learn more about the available formats in our guide to medical cannabis flower, oils and pastilles.
HHC FAQs
Does HHC Get You High?
HHC can produce psychoactive effects. Research suggests that the 9R form has THC-like activity, while 9S-HHC appears to be much less active.
Is HHC the Same as THC?
No. HHC and THC are chemically related cannabinoids, but they are not identical. HHC has a slightly different molecular structure and commercial HHC usually contains a mixture of two epimers with different levels of activity.
Does HHC Show Up on a Drug Test?
It can. Studies have shown that HHC and some of its metabolites can cross-react with cannabinoid screening tests, potentially producing a positive result.
Can You Build a Tolerance to HHC?
There is not enough clinical evidence to define HHC tolerance reliably. Because HHC acts on cannabinoid receptors in a THC-like way, tolerance is biologically plausible, but more human research is needed.
What Is HHC-O?
HHC-O, or HHC acetate, is a chemically modified derivative of HHC. Research into its effects and safety is extremely limited, and it is not an established prescribed cannabis medicine in the UK.
Is HHC a Medical Cannabis Product?
HHC is not an established medicine within routine UK medical cannabis prescribing. Patients considering cannabis-based treatment should follow a regulated clinical pathway rather than relying on unregulated HHC products.
Final Thoughts
HHC is a semi-synthetic cannabinoid with THC-like psychoactive effects. Human research is beginning to emerge, but the evidence remains limited and there is still considerable uncertainty around long-term safety, dosing and product consistency.
It should not be treated as a simple or safe legal alternative to THC. The UK is actively strengthening controls around psychoactive semi-synthetic cannabinoids, while products sold outside regulated medical pathways may vary considerably in composition and strength.
If you’re considering cannabis-based treatment, the safer route is a legal medical assessment with a specialist clinician rather than experimenting with unregulated cannabinoid products.
Curious if You’re Eligible?
Use our free eligibility checker to see whether a specialist medical cannabis assessment may be appropriate for you.
